ENZN Financial Facts
General and administrative: 146KWeighted average shares – basic (in Shares): -88.33M
See Full Income Statement
Total liabilities and stockholders’ equity: -51.12M
Additional paid-in capital: 90.28M
See Full Balance Sheet
Enzon Pharmaceuticals Inc. (ENZN) Earnings
|
Expand Research on ENZN
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/14/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/18/24 |
Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/24 |
Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/26/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/24 | Q224 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/27/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |


